RecruitingPhase 2NCT05181891

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Sponsor

Washington State University

Enrollment

205 participants

Start Date

Jul 11, 2022

Study Type

INTERVENTIONAL

Conditions

Nicotine Use Disorder Alcohol Use Disorder (AUD)

Summary

Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Contingency Management and a behavioral approach called Non-contingent control for people with alcohol use disorder (aud) and nicotine use disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALContingency Management

Incentives for submitting negative-alcohol urine samples

BEHAVIORALNon-contingent control

Incentives for submitting urine samples

Locations(1)

Washington State University

Spokane, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05181891

Related Trials

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

NCT068372201 location

Optimizing Smart Technology for Addiction Recovery

NCT075735401 location